Search results for "Hepatitis C"
Did you mean "hepatitis"?
Sort by: Relevance | Newest | OldestMaking strides to stamp out HCV
While there's a goal of eliminating viral hepatitis globally by 2030, reports indicate a disproportionately high rate of infection and death in the United States among medically underserved populations.
https://immattersacp.org/archives/2024/05/making-strides-to-stamp-out-hcv.htm
1 May 2024
USPSTF expands hepatitis C screening recommendation to most adults
All adults ages 18 to 79 years should now be screened at least once, but people who use injection drugs and pregnant women may require screening more often.
https://immattersacp.org/weekly/archives/2020/03/10/2.htm
10 Mar 2020
MKSAP Quiz: follow-up visit for hepatitis C screening
A 55-year-old man is evaluated in follow-up after a recent routine screening for antibody to hepatitis C virus (HCV) was positive. His medical history is unremarkable; he has not used illicit drugs or had any history of blood transfusions. He currently feels well and takes no medications. Following a physical exam and lab studies, what is the most appropriate diagnostic test to perform next?
https://immattersacp.org/weekly/archives/2016/02/02/3.htm
2 Feb 2016
Recall of glucose test strips; approval for hepatitis C drug
This update covers a class I recall of blood glucose test strips which might cause clinicians to overlook hypoglycemia.
https://immattersacp.org/archives/2016/04/fda.htm
1 Apr 2016
ACP and the American Academy of HIV Medicine collaborate on new guide to hepatitis C testing
The new guide includes a summary of the latest testing recommendations; diagnostic, billing, and laboratory codes for testing; resources for referrals to HCV-experienced clinicians; and information on patient interactions, education, conversations, and case examples.
https://immattersacp.org/weekly/archives/2017/05/16/5.htm
16 May 2017
Point-of-care HCV test, new Alzheimer's drug approved
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2024/09/point-of-care-hcv-test-new-alzheimers-drug-approved.htm
1 Sep 2024
New hepatitis C treatments cost-effective, may exceed insurers' willingness to pay
New therapies for hepatitis C are cost-effective for some patients, according to a study, but high costs may become a barrier to use.
https://immattersacp.org/weekly/archives/2015/03/31/5.htm
31 Mar 2015
Hepatitis C drugs offer new options
The approval of multiple drugs in 2013 and 2014 that are able to cure hepatitis C without the use of interferon has dramatically changed the screening, treatment, and epidemiologic paradigms of the virus. Soon, internists will be involved in this rapidly changing area of health care.
https://immattersacp.org/archives/2015/01/hepatitis.htm
1 Jan 2015
Screening for latent TB may miss higher-risk patients
A study of one large U.S. health system found that risk factors for latent tuberculosis (TB) were not associated with greater likelihood of screening.
https://immattersacp.org/weekly/archives/2024/01/23/4.htm
23 Jan 2024
Controlling hypertension, curing HCV, and more stories
Helping a patient get their hypertension under control is one thing, but helping them keep it there is quite another.
https://immattersacp.org/archives/2024/05/controlling-hypertension-curing-hcv-and-more-stories.htm
1 May 2024